J Korean Diabetes.  2021 Mar;22(1):6-11. 10.4093/jkd.2021.22.1.6.

Diabetes and Vitamin D

• Hong JH

• KMID: 2526174
• DOI: http://doi.org/10.4093/jkd.2021.22.1.6

Abstract

Renewed interest in vitamin D has occurred recently because it has been linked to diabetes mellitus, cardiovascular disease, autoimmune disease, infection, and cancer. Research studies continue to support vitamin D deficiency as correlated with development of diabetes mellitus and progression of diabetes complications. However, most research is based on observational, epidemiological studies, which are important for generating hypotheses but do not prove causality. Furthermore, there is lack of evidence demonstrating the role of vitamin D supplementation in preventing diabetes from a prediabetic state or improving glycemic control and diabetes complications. The purpose of this article is to summarize the latest information related to diabetes and vitamin D.

Keyword

Diabetes complications; Diabetes mellitus; Prediabetic state; Vitamin D

Reference

1. Kayaniyil S., Vieth R., Retnakaran R., Knight JA., Qi Y., Gerstein HC, et al. Association of vitamin D with insulin resistance and beta-cell dysfunction in subjects at risk for type 2 diabetes. Diabetes Care. 2010. 33:1379–81.

2. Song Y., Wang L., Pittas AG., Del Gobbo LC., Zhang C., Manson JE, et al. Blood 25-hydroxy vitamin D levels and incident type 2 diabetes: a meta-analysis of prospective studies. Diabetes Care. 2013. 36:1422–8.

3. Mitri J., Dawson-Hughes B., Hu FB., Pittas AG. Effects of vitamin D and calcium supplementation on pancreatic β cell function, insulin sensitivity, and glycemia in adults at high risk of diabetes: the Calcium and Vitamin D for Diabetes Mellitus (CaDDM) randomized controlled trial. Am J Clin Nutr. 2011. 94:486–94.

4. Maestro B., Molero S., Bajo S., Dávila N., Calle C. Transcriptional activation of the human insulin receptor gene by 1,25-dihydroxyvitamin D(3). Cell Biochem Funct. 2002. 20:227–32.

5. Sergeev IN., Rhoten WB. 1,25-Dihydroxyvitamin D3 evokes oscillations of intracellular calcium in a pancreatic beta-cell line. Endocrinology. 1995. 136:2852–61.

6. Pittas AG., Dawson-Hughes B., Sheehan P., Ware JH., Knowler WC., Aroda VR, et al. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019. 381:520–30.

7. Zhou QG., Hou FF., Guo ZJ., Liang M., Wang GB., Zhang X. 1,25-Dihydroxyvitamin D improved the free fatty-acid-induced insulin resistance in cultured C2C12 cells. Diabetes Metab Res Rev. 2008. 24:459–64.

8. Saif-Elnasr M., Ibrahim IM., Alkady MM. Role of vitamin D on glycemic control and oxidative stress in type 2 diabetes mellitus. J Res Med Sci. 2017. 22:22.

9. Hu Z., Chen J., Sun X., Wang L., Wang A. Efficacy of vitamin D supplementation on glycemic control in type 2 diabetes patients: a meta-analysis of interventional studies. Medicine (Baltimore). 2019. 98:e14970.

10. Li X., Liu Y., Zheng Y., Wang P., Zhang Y. The effect of vitamin D supplementation on glycemic control in type 2 diabetes patients: a systematic review and meta-analysis. Nutrients. 2018. 10:375.

11. Riaz S., Malcangio M., Miller M., Tomlinson DR. A vitamin D(3) derivative (CB1093) induces nerve growth factor and prevents neurotrophic deficits in streptozotocindiabetic rats. Diabetologia. 1999. 42:1308–13.

12. Qu GB., Wang LL., Tang X., Wu W., Sun YH. The association between vitamin D level and diabetic peripheral neuropathy in patients with type 2 diabetes mellitus: an update systematic review and meta-analysis. J Clin Transl Endocrinol. 2017. 9:25–31.

13. Yammine K., Wehbe R., Assi C. A systematic review on the efficacy of vitamin D supplementation on diabetic peripheral neuropathy. Clin Nutr. 2020. 39:2970–4.

14. Lu L., Lu Q., Chen W., Li J., Li C., Zheng Z. Vitamin D(3) protects against diabetic retinopathy by inhibiting high-glucose-induced activation of the ROS/TXNIP/NLRP3 inflammasome pathway. J Diabetes Res. 2018. 2018:8193523.

15. Payne JF., Ray R., Watson DG., Delille C., Rimler E., Cleveland J, et al. Vitamin D insufficiency in diabetic retinopathy. Endocr Pract. 2012. 18:185–93.

16. Nadri G., Saxena S., Mahdi AA., Kaur A., Ahmad MK., Garg P, et al. Serum vitamin D is a biomolecular biomarker for proliferative diabetic retinopathy. Int J Retina Vitreous. 2019. 5:31.

17. Li YC., Qiao G., Uskokovic M., Xiang W., Zheng W., Kong J. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Steroid Biochem Mol Biol. 2004. 89–90:387–92.

18. Li Y., Spataro BC., Yang J., Dai C., Liu Y. 1,25-dihydroxyvitamin D inhibits renal interstitial myofibroblast activation by inducing hepatocyte growth factor expression. Kidney Int. 2005. 68:1500–10.

19. Thrailkill KM., Jo CH., Cockrell GE., Moreau CS., Fowlkes JL. Enhanced excretion of vitamin D binding protein in type 1 diabetes: a role in vitamin D deficiency? J Clin Endocrinol Metab. 2011. 96:142–9.

20. Derakhshanian H., Shab-Bidar S., Speakman JR., Nadimi H., Djafarian K. Vitamin D and diabetic nephropathy: a systematic review and meta-analysis. Nutrition. 2015. 31:1189–94.

21. de Boer IH., Zelnick LR., Ruzinski J., Friedenberg G., Duszlak J., Bubes VY, et al. Effect of vitamin D and omega-3 fatty acid supplementation on kidney function in patients with type 2 diabetes: a randomized clinical trial. JAMA. 2019. 322:1899–909.

22. Farrokhian A., Raygan F., Bahmani F., Talari HR., Esfandiari R., Esmaillzadeh A, et al. Long-term vitamin D supplementation affects metabolic status in vitamin D-deficient type 2 diabetic patients with coronary artery disease. J Nutr. 2017. 147:384–9.

23. Bahrami LS., Ranjbar G., Norouzy A., Arabi SM. Vitamin D supplementation effects on the clinical outcomes of patients with coronary artery disease: a systematic review and meta-analysis. Sci Rep. 2020. 10:12923.